CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome
about
A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammationInflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.Dynamic impact of brief electrical nerve stimulation on the neural immune axis-polarization of macrophages toward a pro-repair phenotype in demyelinated peripheral nerve.Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy.A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma.Unraveling gene expression profiles in peripheral motor nerve from amyotrophic lateral sclerosis patients: insights into pathogenesis.Attenuation of experimental autoimmune neuritis with locally administered lovastatin-encapsulating poly(lactic-co-glycolic) acid nanoparticles.The clinical significance of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in Guillain-Barré syndrome.A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain.
P2860
Q27303179-D620509D-C218-4775-AA53-8641489868CFQ27303465-D3C9C916-5E23-4D91-9770-1ABFA5B34348Q27322544-E1513528-662F-44B3-84DD-31D2C7932075Q39558493-EDE0E419-E723-4A78-98AF-AF82029A2365Q39647818-909FFA25-666C-4A41-B955-3B5BF128D440Q40444924-D7B33373-DFC4-430D-A9EF-9A30D4BE6DB8Q41009823-1201C1A3-4F86-4E56-B37F-D3A363E5A4C7Q42096382-579EAB20-4F4A-422B-9431-DBD01B5A99E6Q48032010-99E71938-0268-4C76-94E0-980344BD1E60Q49690314-CA0C8E70-ADA6-4A92-A52A-9165EB37F39DQ52601987-39D78623-C260-46E9-AE84-4E16E8653EB4
P2860
CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@ast
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@en
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@nl
type
label
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@ast
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@en
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@nl
prefLabel
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@ast
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@en
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@nl
P2093
P2860
P3181
P1433
P1476
CCR2 gene deletion and pharmac ...... del of Guillain-Barré syndrome
@en
P2093
Ailing Huang
Chetan Lakshmana Reddy
Eroboghene E Ubogu
Furong Yuan
Hafiza Rahman Tithi
Nejla Yosef
Sharon C Chiang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0090463
P407
P577
2014-01-01T00:00:00Z